POSABIT SYSTEMS CORPORATION (POSAF)
POSaBIT to Host Second Quarter 2026 Earnings Conference Call
POSaBIT to Host Second Quarter 2026 Earnings Conference Call
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Une analyse de Riskified révèle que les fraudeurs du secteur du voyage s’adaptent trop rapidement pour que les indicateurs traditionnels puissent les suivre efficacement, et que le risque lié aux vols a connu une hausse de 32 % au mois de mai
Definium Therapeutics Announces New Employee Inducement Grants
GenFlat and Group Global One Launch Collapsible Container Trial in Vietnam
Amylyx Pharmaceuticals to Announce Topline Results from its Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia on August 18, 2026